. Author manuscript; available in PMC: 2020 Nov 1.

Published in final edited form as: Cancer Discov. 2020 Mar 25;10(5):674–687. doi: 10.1158/2159-8290.CD-20-0215

Table 1:

Patient Characteristics.

Characteristics	N (%)
Total patients treated	49 (100)
Age, median	64 (range 25–84)
Sex, Female	35 (71)
Smoking status
Former smoker	25 (51)
Never	24 (49)
Histology
Adenocarcinoma	47 (96)
Large cell neuroendocrine carcinoma	1 (2)
Non-small cell lung cancer not otherwise specified	1 (2)
Median line of therapy for T-DM1	2 (range 1–7)
1^st line	5 (10)
2^nd line	23 (47)
3^rd line	12 (24)
4^th line	5 (10)
5^th line	2 (4)
6^th line	1 (2)
7^th line	1 (2)
Prior HER2-targeted therapy	9 (50%)
Afatinib	6 (12)
Neratinib	6 (12)
Trastuzumab	5 (10)
Pertuzumab	1 (2)